SynthesisUltrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology2026
Hemodynamics-guided treatment of hypertensive disorders of pregnancy: systematic review and meta-analysis.
Synthesis in Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo determine whether antihypertensive therapy guided by maternal hemodynamic assessment improves maternal and perinatal outcomes in women with hypertensive disorders of pregnancy (HDP) compared with standard care based on blood-pressure thresholds.
methodsThis was a systematic review and meta-analysis of randomized and non-randomized comparative studies comparing hemodynamics-guided management vs standard antihypertensive care in women with HDP. PubMed/MEDLINE and The Cochrane Library were searched from inception until 15 June 2025 for eligible studies. Outcome data were extracted for pre-eclampsia/eclampsia, HELLP syndrome, severe hypertension, fetal growth restriction, placental abruption, preterm birth and perinatal death. The composite adverse outcome included all abovementioned outcomes. The risk of bias was assessed using the Risk Of Bias In Non-Randomized Studies of Interventions tool, the revised Cochrane Risk-of-Bias tool and the Newcastle-Ottawa scale. Certainty of evidence was assessed using Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology. Odds ratios (OR) were pooled using random-effects models, with heterogeneity quantified by I
resultsThe literature search retrieved six studies, including one randomized controlled trial, four non-randomized comparative studies and one multicenter prospective cohort study. Depending on the outcome analyzed, 418-614 patients were included in the intervention group and 617-731 patients in the control group. Compared with standard care, hemodynamics-guided therapy reduced the odds of pre-eclampsia/eclampsia by 53% (OR, 0.47 (95% CI, 0.33-0.65); I
conclusionsHemodynamics-guided antihypertensive management of women with HDP was associated with reductions in several adverse maternal and perinatal outcomes compared with standard care. Given the predominance of non-randomized study designs, measurement heterogeneity and risk of residual confounding, these associations should be interpreted as hypothesis-generating and require confirmation in adequately powered randomized controlled trials. © 2026 International Society of Ultrasound in Obstetrics and Gynecology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.